Analyst Ratings for IMS Health Holdings Inc (IMS)Updated: 2016-10-01
Investment analysts gave a few price targets for IMS. The most optimistic analyst gave a price target of 34, implying potential capital gains of 8.49 percent. The most pessimistic price target was 25, which equates to a potential downside of -20.23 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.
Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is 2.78 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 1.91 percent in FY estimates.
Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.
IMS has an estimated earnings growth rate of 277.44 percent as forecasted by analysts. It's possible to gain additional insight about growth valuation of a company by looking at the PEG ratio. Investors like to see smaller values for the PEG ratio, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, though it could be better to see where the ratio stands relative to peers in the industry. The PEG ratio of IMS is 0.27.
IMS has traded between a high of 31.59 and a low of 22.36 over the past year. The current market price is above the trailing year's low by 40.16 percent, and 0.79 percent below the high. IMS has a P/E ratio of 75.45. Investors typically compare the P/E ratio to a company's peers in the industry. The IMS value stock report compares IMS to some of its peers using value stock charts. The stock has a market capitalization of $10.59 billion. IMS will post this quarters earnings in -1025 days, on 2016-10-27.